Filing Determination and Review PlanningFrom the time a marketing application is submitted, FDA has 60 days to perform an initial review. During this time FDA will determine if the submission is sufficiently complete to perform a more substantive review.
Day 60 post-submission is designated as the filing decision date.Prior to the filing decision date, each review discipline will make a recommendation about the “file-ability” of the application.If the initial review uncovers deficiencies, FDA may alert the sponsor at any time using information requests and/or may note the deficiencies as part of the filing letter.
Refuse to file designations are made by Day 60 post filing.
If the 60 day is a calendar 60 days, it’s getting close to crunch time..
- Forums
- ASX - By Stock
- MSB
- trial time
trial time, page-36
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.10 |
Change
-0.038(3.29%) |
Mkt cap ! $1.278B |
Open | High | Low | Value | Volume |
$1.14 | $1.17 | $1.10 | $5.677M | 4.996M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 289670 | $1.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.11 | 48485 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 119080 | 1.105 |
24 | 332403 | 1.100 |
11 | 54288 | 1.095 |
9 | 121287 | 1.090 |
8 | 459182 | 1.085 |
Price($) | Vol. | No. |
---|---|---|
1.110 | 24029 | 13 |
1.115 | 120534 | 21 |
1.120 | 133179 | 15 |
1.125 | 107605 | 12 |
1.130 | 200380 | 9 |
Last trade - 14.21pm 19/06/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
INF
INFINITY LITHIUM CORPORATION LIMITED
Ryan Parkin, Managing Director & CEO
Ryan Parkin
Managing Director & CEO
Previous Video
Next Video
SPONSORED BY The Market Online